

| Numéro de catalogue | DF879048 |
|---|---|
| Description |
Infliximab ELISA Kit (DF879048) — Quantitative competitive ELISA for Infliximab. Sample: Plasma, Serum. Range: 0.31-5 μg/mL. Sensitivity: 0.156 μg/ml.
Highlights
|
| Type d'échantillon | Plasma, Serum |
| Sensibilité | 6.82 ng/ml |
| Plage | 125-8,000 ng/ml |
| Numéro d'accès | CAS: 170277-31-3 |
| Applications | ELISA |
| Méthode de détection | Colorimetric |
| Type de test | Quantitative |
| Retraitement | 80-120% |
| Expédition | 2-8 ℃ |
| Stabilité et stockage | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
| Spécifications | Infliximab |
| Noms alternatifs | TA-650, cA2, 170277-31-3 |
| Contexte | Infliximab is a chimeric monoclonal antibody and used to treat auto- immune disorders. Infliximab reduces the amount of active human tumour necrosis factor alpha (hTNFa) in the body by binding to it and preventing it from signaling the receptors for TNFa on the surface of various cell types. TNFa is one of the key cytokines that triggers and sustains the inflammatory reactions. Infliximab is used for the treatment of psoriasis, Crohn’s disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis. |
| Note | For Research Use Only. |

Standard Curve of Infliximab ELISA Kit




Contactez-nous pour les devis personnalisés, les demandes en gros et tout autre problème.
Courrier : [email protected]


+86-027-65523339
Bâtiment C, No. 666, Rue Shendunsi, Wuhan, 430206, Chine
中文
English
한국어
日本語
Español
Français
Русский